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Introduction: Eating disorders are diagnosed in 5 to 10 Million persons annually.  The trend in 
recent years indicates the population afflicted with eating disorders is primarily women from 
diverse backgrounds and the occurrence of substance abuse as a co-occurring disorder is on the 
rise. The number of persons suffering from bulimia nervosa and a co-occurring substance use 
disorder ranges from 3% to 50% which far exceeds those diagnosed with other eating disorders 
or in the general population.  As a result, treatment providers are utilizing integrated treatment 
models for patients with co-occurring bulimia nervosa and substance use disorders. 
 
Purpose:  The purpose of this study was to examine the prevalence of persons seeking treatment 
diagnosed with bulimia nervosa and a co-occurring substance use disorder. Also, to identify the 
outcome based treatment interventions currently utilized by treatment providers. 
 
Method:  Data was collected by reviewing academically peer reviewed journal articles that 
discussed research in the areas of the diagnosis and treatment of co-occurring Bulimia Nervosa 
and Substance Use disorders. In addition, data was collected by calling three Atlanta based 
treatment centers and discussing the most effective treatment modalities utilized for co-occurring 
bulimia nervosa and substance use disorders. 
 
Results:  The data indicates that persons diagnosed with an eating disorder have a higher rate of 
substance use than those who do not have an eating disorder. According to The National Center 
on Addiction and Substance Abuse at Columbia University (2003), girls who suffer from eating 
disorders are consistently higher in all categories of substance abuse:  nicotine 45.6% / 21.6%, 
alcohol 63.9%/38.6%, marijuana 31.5%/16.1%, Inhalants 9.2%/2.4% and for “other drugs” 
8.0%/2.2%. Research of the literature has indicated that Cognitive Behavioral Therapy (CBT) 
when implemented as an integrated treatment intervention has the highest rate of positive 
outcome for the treatment of bulimia nervosa and substance use disorders. 
 
Conclusion: The rate of bulimia nervosa and substance use disorders has a high prevalence rate 
when compared to other diagnostic categories of eating disorders. This increased rate of 
occurrence presents treatment providers with the impetus to utilize effective outcome based 
treatment interventions. Integrated Cognitive-Behavioral Therapy (CBT) has been reported as 
being effective in the treatment of Bulimia Nervosa and Co-occurring Substance Use Disorders.   
 
Recommendations: The lack of research and study outcomes available on the integrated CBT 
approach to treatment of these co-occurring disorders calls for additional research in this area.   
Future studies are needed to evaluate the efficacy of this integrated approach in the treatment 
when both disorders are co-occurring in patients.  
